Answers to 10 Frequently Asked Questions About Metastatic Breast Cancer
Here are answers to 10 questions patients asked at the CURE® Educated Patient® Metastatic Breast Cancer Summit about scans, treatment and clinical trials.
Read More
Oncologist Debunks Clinical Trial Myths
Before enrolling in a clinical trial for metastatic breast cancer, it’s important to know which are best suited for each individual, an expert said.
Palliative Care’s Role in Helping Patients With Breast Cancer, Their Families
One specialist explained the ways palliative care, also known as supportive care, can assist patients during a breast cancer journey.
Integrative Methods Address Common Breast Cancer Quality-of-Life Issues
At the CURE® Educated Patient® Breast Cancer Summit, an expert discussed integrative methods that can improve quality of life.
Biomarker Testing Is Essential in HR-Positive Metastatic Breast Cancer
Patients with HR-positive metastatic breast cancer can expect to undergo biomarker testing both at diagnosis and again if the disease progresses.
Side Effects to Monitor During HER2-Positive Breast Cancer Treatment
One expert explained the common side effects at every line of treatment for metastatic HER2-positive breast cancer during the CURE® Educated Patient® Metastatic Breast Cancer Summit.
How Targeted Therapies Changed Lung Cancer Treatment
One expert explains why “the future of precision medicine” has arrived in lung cancer at the CURE® Educated Patient® Lung Cancer Summit.
A Personalized Approach to Combining Drugs and Surgery for NSCLC
Tumor characteristics are used to determine the best method of combining therapies with surgery for non-small cell lung cancer, according to a presentation at the CURE® Educated Patient® Lung Cancer Summit.
CAR-T Moving to Earlier Availability in Multiple Myeloma
During the CURE® Educated Patient® Multiple Myeloma Summit, one expert explained the push to make CAR-T cell therapy available for patients sooner.
Combining Drugs, Radiation Is ‘Practice-Changing’ for Some Lung Cancer Subsets
Radiation plus targeted or immunotherapies could be beneficial for certain patients with lung cancer, and expert said at the CURE® Educated Patient® Lung Cancer Summit.
The Role of Biomarker Testing for Personalized Therapy in Lung Cancer
Patients with lung cancer may have personalized treatment options after biomarker testing, an expert said at the CURE® Educated Patient® Lung Cancer Summit.
Understanding Immunotherapy and Side Effects in Advanced Lung Cancer
Treatment for lung cancer has changed significantly with immunotherapy, an expert said during the CURE® Educated Patient® Lung Cancer Summit.
Multiple Myeloma Progression Still Slowed With Reduced Tecvayli Dosing
Data show that patients’ multiple myeloma still fails to progress if patients receive less-frequent Tecvayli.
Don’t Delay Bringing Up CML Concerns, a Doctor Says
To ensure best outcomes, patients with chronic myeloid leukemia should maintain frequent communication with their care teams — even between appointments.
Watch
Most Patients With CML Can Continue Their Normal Lifestyle During Treatment
Most — though not all — side effects from chronic myeloid leukemia treatment improve over time, an expert said.
Organizations Can Help Patients with CML Face the ‘Long Treatment Journey’
A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.
Bispecific Antibodies Get ‘Fantastic’ Responses in Pretreated Myeloma
As part of the CURE® Educated Patient® Summit, one expert reviewed the landscape of bispecific antibodies, such as Tecvayli, for multiple myeloma.
Putting Quality of Life into Perspective During CML Treatment
Patients with chronic myeloid leukemia should be upfront with their care team about how treatment side effects are affecting their daily functioning.
Determining Stem Cell Transplant Eligibility, Quality of Life in Myeloma
Quality of life may temporarily worsen after patients with myeloma receive stem cell transplants, said an expert at the Educated Patient® Multiple Myeloma Summit.
Understanding the Disease, Treatments Help Patients Navigate a CML Diagnosis
Initial discussions about treatment, side effects and study results can help patients navigate through all aspects of a chronic myeloid leukemia diagnosis.
3 Questions to Ask Doctors After a CML Diagnosis
An advocate discusses vital patient-provider conversations to promote the best care for individuals with chronic myeloid leukemia.
Tumor Treating Fields for Brain Metastases in Lung Cancer Boost Quality of Life With Some Trade-Offs
For patients with non-small lung cancer and brain metastases, it’s important to consent to shaving the scalp before tumor-treating fields therapy.
Drug Combos Improve Outcomes in Newly Diagnosed Myeloma
New drug combinations and sequences are being investigated and may improve outcomes for patients with newly diagnosed myeloma, an expert explained at the Educated Patient® Multiple Myeloma Summit.
Tecvayli Responses Continue for Two Years in R/R Multiple Myeloma
Data from the MajesTEC-1 trial shows that patients with relapsed/refractory multiple myeloma responded to Tecvalyi for a median of two years and lived without disease progression for nearly a year.
4-Drug Regimen Boosts Time to Progression in Newly Diagnosed Myeloma
Sarclisa, Velcade, Revlimid and dexamethasone improved progression-free survival in patients with multiple myeloma who were not eligible for transplant.
Patients With Stage 3 Melanoma Should Discuss Adjuvant Therapy
Patients with resectable stage 3 melanoma should talk about pretreatment therapy with their cancer care teams, an expert said.
Padcev Plus Keytruda Doesn’t Worsen Quality of Life in Bladder Cancer
Padcev and Keytruda improve survival and progression among patients with bladder cancer, but don’t adversely impact pain, functioning or quality of life.
Trodelvy Improves Quality of Life Over Chemo in TNBC
Trodelvy led to better disease control and improved quality of life compared to chemotherapy in patients with triple-negative breast cancer.
Keytruda Plus Chemo May Improve Penile Cancer Outcomes
Keytruda plus platinum-based chemotherapy appeared to be safe and effective in treating penile squamous cell carcinoma.
Padcev Improves Outcomes for Cisplatin-Ineligible Bladder Cancer
For patients with cisplatin-ineligible bladder cancer, presurgical Padcev decreased the cancer stage without leading to delays in surgery.